Sarepta Therapeutics Inc.
SRPT | NASDAQ
$18.24
-$0.38 (-2.04%)
Nov 2, 2026, 3:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.2B | 1.9B | 1.24B | 933.01M | 701.89M | 540.1M |
Cost of Revenue | 881.5M | 319.1M | 150.34M | 139.99M | 97.05M | 63.38M |
Gross Profit | 1.32B | 1.58B | 1.09B | 793.02M | 604.84M | 476.72M |
Operating Income | -657.77M | 218.08M | -267.82M | -536.2M | -459.71M | -564.16M |
Interest Income | 19.57M | 71.77M | 85.97M | 27.72M | 511K | 2.97M |
Pretax Income | -702.23M | 260.77M | -520.1M | -689.96M | -418.95M | -553.07M |
Net Income | -713.41M | 235.24M | -535.98M | -703.49M | -418.78M | -554.13M |
Selling & General & Admin | 478.94M | 557.87M | 481.87M | 451.42M | 282.66M | 317.88M |
Research & Development | 1.52B | 804.52M | 877.39M | 877.09M | 771.18M | 722.34M |
Other Expenses | -26.5M | 2.41M | 1.56M | 714K | 10.71M | 662K |
Operating Expenses | 1.97B | 1.36B | 1.36B | 1.33B | 1.06B | 1.04B |
Interest Expense | 9.73M | 18.39M | 22.01M | 53.25M | 63.53M | 59.95M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.86B | 1.68B | 1.51B | 1.47B | 1.16B | 1.1B |
Income Tax Expense | 11.19M | 25.54M | 15.88M | 13.53M | -168K | 1.06M |
Shares Outstanding (Basic) | 104.79M | 95.08M | 92.4M | 87.56M | 81.26M | 77.96M |
Shares Outstanding (Diluted) | 104.79M | 107.88M | 92.4M | 87.56M | 81.26M | 77.96M |
EPS (Basic) | -7.13 | 2.47 | -5.80 | -8.03 | -5.15 | -7.11 |
EPS (Diluted) | -7.13 | 2.34 | -5.80 | -8.03 | -5.15 | -7.11 |
EBITDA | -647.97M | 316.89M | -453.69M | -594.85M | -317.41M | -453.38M |
EBIT | -692.49M | 279.17M | -498.09M | -636.72M | -355.42M | -493.12M |
Depreciation & Amortization | 44.52M | 37.72M | 44.4M | 41.86M | 38.02M | 39.74M |
Add to Watchlist
Select watchlists to add or remove SRPT